Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carlyle Group
MedTech
Baxter sells $4.5B kidney care unit to Carlyle Group for $3.8B
Baxter estimated it will net about $3 billion in cash for the company and its about 23,000 employees, which were once slated to go independent.
Conor Hale
Aug 13, 2024 11:00am
Abingworth channels $356M into late-stage clinical programs
Oct 30, 2023 10:55am
Carlyle Group in talks to close $7B Medtronic spinoff deal
Oct 2, 2023 10:27am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
Investment firm Carlyle snaps up majority stake in TriNetX
Sep 22, 2020 8:05am
Singapore, UAE government funds’ new investments put PPD at $9B
Apr 28, 2017 9:08am
